Psoriatic Disease News

SAN DIEGO — Modulation of psoriasis biomarkers and pathways were observed in patients who experienced clinical success with TAK-279, according to phase 2b trial results.

SAN DIEGO — A lower concentration of intralesional triamcinolone acetonide was as efficacious as higher concentrations for nail psoriasis.

SAN DIEGO — In this video perspective, Healio Dermatology Chief Medical Editor Joel M. Gelfand, MD, MSCE, discusses highlights from the LITE study on home vs. office-based phototherapy for plaque or guttate psoriasis.

Izokibep achieved the primary endpoint of ACR50 response in a phase 2b/3 psoriatic arthritis trial, and demonstrated sustained, “deepening” benefit in hidradenitis suppurativa, according to top-line data from its manufacturer.

Screening patients with psoriasis, uveitis or inflammatory bowel disease for spondyloarthritis could improve early diagnosis, but no existing screening tools are generalizable to all who are at risk, according to a scoping review.

Pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although immune-mediated inflammatory diseases in general are “only weakly associated” with adverse pregnancy outcomes, according to data.

Fatigue among patients with psoriasis with or without psoriatic arthritis was associated with joint paint, itch and, to a lesser extent, disease severity, according to a study.

The order in which moisturizer and fixed-combination halobetasol propionate 0.01% and tazarotene 0.045% were applied did not affect efficacy, but it had a possible impact on tolerability in adults with psoriasis, according to a study.

The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.

Patients with plaque or guttate psoriasis treated with at-home phototherapy experienced similar benefits to those treated in-office, according to topline study data.